Insulet Corp. stock underperforms Tuesday when compared to competitors
Shares of Insulet Corp. PODD shed 1.03% to $265.65 Tuesday, on what proved to be an all-around grim trading session for the ...
Insulet Corp. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Insulet price target raised to $315 from $305 at Bernstein
Bernstein raised the firm’s price target on Insulet (PODD) to $315 from $305 and keeps an Outperform rating on the shares as part of a broader ...
What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?
Insulet Corporation ( NASDAQ:PODD ) saw a double-digit share price rise of over 10% in the past couple of months on ...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
TD Cowen Boosts Insulet (NASDAQ:PODD) Price Target to $324.00
Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to ...
Bank of America Securities Keeps Their Buy Rating on Insulet (PODD)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of ...
Looking Into Insulet's Recent Short Interest
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Buying $100 In PODD: If an investor had bought $100 of PODD stock 10 years ago, it would be worth $598.02 today based on a ...
Nasdaq5d
Insulet price target raised to $324 from $264 at TD Cowen
TD Cowen raised the firm’s price target on Insulet (PODD) to $324 from $264 and keeps a Buy rating on the shares. The firm thinks Insulet will continue to deliver “beat-and-raise performances ...
Nasdaq12d
Is Insulet Stock Outperforming the Dow?
Valued at a market cap of $18.5 billion, Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The Massachusetts-based ...